Renal cell carcinoma

MET - Renal cell carcinoma, papillary type 1

This test is available for the following conditions:

• Conditions > Renal / Nephrological > Renal cell carcinoma
• Conditions > Oncogenetics > Renal cell carcinoma

This product is also part of the following panels:

• panel hereditary renalcancer (SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, PTEN, FLCN, MET, FH, BAP1)
• WES comprehensive preconception carrier test ¹
• WES hearing impairment (including GJB2) (100.0% *)
• WES hereditary cancer (100.0% *)
• WES Mendelian inherited disorders (100.0% *)
• WES short stature/skeletal dysplasia (100.0% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

• Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 164860
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA

---